The Thrombopoietin/MPL pathway in hematopoiesis and leukemogenesis
Citations Over TimeTop 13% of 2011 papers
Abstract
Hematopoietic stem cells (HSC) comprise a small percentage of total hematopoietic cells. Their ability to self-renewal is key to the continuous replenishment of the hematopoietic system with newly formed functional blood cell types while maintaining their multipotential capacity. Understanding the extrinsic signals that are essential to HSC maintenance will provide insights into the regulation of hematopoiesis at its most primitive stage, and with the knowledge applied, will potentially lead to improved clinical transplantation outcomes. In this review, we will summarize the current understanding of the role of the thrombopoietin/MPL signaling pathway in HSC maintenance during adult and fetal hematopoiesis. We will also speculate on the downstream key players in the pathway based on published data, and summarize the role of this pathway in leukemia.
Related Papers
- → Relationship between megakaryocyte mass and serum thrombopoietin levels as revealed by a case of cyclic amegakaryocytic thrombocytopenic purpura(1999)36 cited
- → The additive effects of combined murine nuclear migration protein with murine thrombopoietin in vitro and in vivo on normal and myelosuppressed mice(2011)2 cited
- The role of thrombopoietin in chronic hepatitis B patients with thrombocytopenia(2008)
- Prognosis of Idiopathic Thrombocytopenic Purpura in Serum Levels of Thrombopoietin and Number of Megakaryocyte(2006)
- Measurement of Serum Thrombopoietin Levels in Patients with Thrombocytopenia(2005)